Correlation Between Regen BioPharma and Marizyme

Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regen BioPharma and Marizyme, you can compare the effects of market volatilities on Regen BioPharma and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Marizyme.

Diversification Opportunities for Regen BioPharma and Marizyme

0.26

Correlation Coefficient

Regen BioPharma  Marizyme

Modest diversification

The 3 months correlation between Regen and Marizyme is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Marizyme go up and down completely randomly.

Pair Corralation between Regen BioPharma and Marizyme

Given the investment horizon of 90 days Regen BioPharma is expected to generate 1.98 times more return on investment than Marizyme. However, Regen BioPharma is 1.98 times more volatile than Marizyme. It trades about 0.16 of its potential returns per unit of risk. Marizyme is currently generating about 0.08 per unit of risk. If you would invest  8.99  in Regen BioPharma on September 12, 2024 and sell it today you would lose (1.49) from holding Regen BioPharma or give up 16.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Regen BioPharma  vs.  Marizyme

Regen BioPharma

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Marizyme

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Marizyme are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Marizyme displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regen BioPharma and Marizyme

The main advantage of trading using opposite Regen BioPharma and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.

The idea behind Regen BioPharma and Marizyme pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.